Close Menu

NEW YORK ─ Shares of Luminex rose as much as 16 percent in Thursday trading on the Nasdaq following a report that DiaSorin is considering acquiring it.

The company's shares finished Thursday up almost 10 percent at $32.99.

DiaSorin's shares rose by more than 3 percent to €163.70 ($200) on the Italian stock exchange in Milan.

Investor demand drove up the share prices after Bloomberg, citing unnamed sources, reported on Thursday that DiaSorin is working with advisors to evaluate a potential acquisition of Austin, Texas-based Luminex.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.